Bioequivalency, Clinical Development, Containment and Generic Drugs

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Bioequivalency

Clinical Development

Containment

Generic Drugs

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

Delveinsight

FEBRUARY 5, 2021

Some of these approved products contain nicotine as an active ingredient, while others do not. Moreover, the generic drugs of Zyban are also approved, while for Chantix, its patent is soon going to expire in 2021 in the EU and in 2022 in Japan. Generics in the Market.

Marketing

Marketing FDA Approval Branding Production

TLC Provides Corporate Update at Investor Conference – Dec 18, 2020

The Pharma Data

DECEMBER 17, 2020

In addition, TLC is preparing for scale-up production of TLC590, as for complex lipid products, the manufacturing process and batch size used in pivotal clinical trials and New Drug Application submission must be the same as future commercial batches. Cautionary Note on Forward-Looking Statements. Source link.

Clinical Trials

Clinical Trials Clinical Trials Trials Containment

Clinical Research Informer

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

TLC Provides Corporate Update at Investor Conference – Dec 18, 2020

Stay Connected